Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

R. Martin Emanuele Net Worth & Insider Trades

R. Martin Emanuele - Senior VP, Adventrx Pharmaceuticals Inc

As of January 18, 2013

What is R. Martin Emanuele's Net Worth?

The current estimated net worth of Adventrx Pharmaceuticals Inc's Senior VP, R. Martin Emanuele, is estimated to be about $350.78K . R. Martin Emanuele owns about 547,663 units of Adventrx Pharmaceuticals Inc common stock. In the last 2 years at Adventrx Pharmaceuticals Inc, R. Martin Emanuele has sold an estimated value of $24.74K worth.

What is R. Martin Emanuele's Past Insider Trading?

R. Martin Emanuele's largest sale order was 41,000 units , worth over $24.43K on December 19, 2011. In total, R. Martin Emanuele has made about 2 transactions over 2 years of their time at Adventrx Pharmaceuticals Inc. R. Martin Emanuele usually trades in December and January, with the busiest year in 2013 and 2011.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

R. Martin Emanuele

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Adventrx Pharmaceuticals Inc's Past Insider Trades?

Adventrx Pharmaceuticals Inc's most recent insider trade came on May 14, 2012 by David A Ramsay who bought 50,000 units worth $26.96K . In the last 7 years, insiders at Adventrx Pharmaceuticals Inc have sold an estimated value of $535.49K and bought an estimated value of $589.07K worth of shares. Insider trading is most common in July, with the busiest year in 2006. The most active traders at the company are Brian M Culley, CEO and Director,  Patrick L Keran, President & COO,  and Evan Levine, CEO & President .

ADVENTRX PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...